What Remiges Does
Remiges Ventures creates new companies based on intellectual properties from the Japanese academia. Historically Japan is the globe’s third richest source of biopharma seed technologies. We create companies based on innovative science and seed products, manage the company formation stage by our own team and move the product development towards the Series A stage. Remiges Ventures also has its own research activities through collaborations with academic institutions and CROs to validate hypotheses and evaluate assets from multiple angles.
Early Stage Investment
Remiges Ventures takes a lead position for the syndication of Series A or later stage of investment rounds globally. Remiges Ventures’ team is connected with KOLs in various therapeutic areas, serial entrepreneurs, key consultants and pharma BD people. We the Remiges team actively participate in the value creation for its portfolio companies.